LPCAT1 expression is correlated with prognosis and survival in clear cell renal cell carcinoma, breast cancer, and prostate cancer [137,138,139,140] and can be used as a diagnostic marker in prostate cancer and esophageal cancer [139,141]. Here, LPCAT1 is linked to breast cancer.